These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2813838)
1. Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity. Dische S; Saunders MI Radiother Oncol; 1989 Sep; 16(1):65-72. PubMed ID: 2813838 [TBL] [Abstract][Full Text] [Related]
2. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100 [TBL] [Abstract][Full Text] [Related]
3. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Dische S; Saunders M; Barrett A; Harvey A; Gibson D; Parmar M Radiother Oncol; 1997 Aug; 44(2):123-36. PubMed ID: 9288840 [TBL] [Abstract][Full Text] [Related]
4. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer. Saunders MI; Rojas AM; Parmar MK; Dische S; Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851 [TBL] [Abstract][Full Text] [Related]
7. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer. Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958 [TBL] [Abstract][Full Text] [Related]
8. CHART revisited: a conservative approach for advanced head and neck cancer. Saunders M; Rojas AM; Dische S Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):127-33. PubMed ID: 18065214 [TBL] [Abstract][Full Text] [Related]
9. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745 [TBL] [Abstract][Full Text] [Related]
10. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081 [TBL] [Abstract][Full Text] [Related]
11. The morbidity of salvage surgery following conventional radiotherapy and continuous, hyperfractionated accelerated radiotherapy (CHART). Rugg T; Lartigau E; Sanders R; Glover G; Saunders MI; Dische S Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):581-6. PubMed ID: 1995544 [TBL] [Abstract][Full Text] [Related]
12. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242 [TBL] [Abstract][Full Text] [Related]
13. Phase I study of hyperfractionated accelerated radiation and simultaneous Carboplatin therapy for advanced head and neck carcinomas. Schnabel T; Zamboglou N; Kolotas C; Jiménez W; Strehl H; Schmitt G Strahlenther Onkol; 1992 Jun; 168(6):318-21. PubMed ID: 1621209 [TBL] [Abstract][Full Text] [Related]
14. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee. Saunders MI; Dische S; Barrett A; Parmar MK; Harvey A; Gibson D Br J Cancer; 1996 Jun; 73(12):1455-62. PubMed ID: 8664112 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer. Mortensen HR; Overgaard J; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen LJ; Andersen E; Grau C Radiother Oncol; 2012 Apr; 103(1):69-75. PubMed ID: 22398313 [TBL] [Abstract][Full Text] [Related]
16. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360 [TBL] [Abstract][Full Text] [Related]
17. Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region. Saunders MI; Dische S; Hong A; Grosch EJ; Fermont DC; Ashford RF; Maher EJ Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1287-93. PubMed ID: 2689397 [TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP; Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362 [TBL] [Abstract][Full Text] [Related]
19. Accelerated radiation therapy in the treatment of very advanced and inoperable head and neck cancers. Lusinchi A; Lartigau E; Luboinski B; Eschwege F Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):149-52. PubMed ID: 8175422 [TBL] [Abstract][Full Text] [Related]
20. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck. Nguyen TD; Demange L; Froissart D; Panis X; Loirette M Cancer; 1985 Jul; 56(1):16-9. PubMed ID: 4005785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]